Identification of Barriers Preventing Biosimiliar Oncology Medication Adoption

(1) Background: A biosimilar is a biologic medical product that has been approved by the United States Food and Federal Drug Administration (FDA) and is an almost identical copy of an original biologic product yet manufactured by a different company. Biosimilars are often assumed to be the same as g...

Descripción completa

Detalles Bibliográficos
Autores principales: Hair, John, Maryon, Thomas, Lieneck, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696566/
https://www.ncbi.nlm.nih.gov/pubmed/36363490
http://dx.doi.org/10.3390/medicina58111533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696566/
https://www.ncbi.nlm.nih.gov/pubmed/36363490
http://dx.doi.org/10.3390/medicina58111533

Ejemplares similares